In Vitro Efficacy of Antivirals and Monoclonal Antibodies against SARS-CoV-2 Omicron Lineages XBB.1.9.1, XBB.1.9.3, XBB.1.5, XBB.1.16, XBB.2.4, BQ.1.1.45, CH.1.1, and CL.1.

Regkirona (regdanvimab) - Celltrion

REGEN-COV (casirivimab/imdevimab) - Regeneron, Roche

bebtelovimab (LY-CoV1404) - AbCellera, Eli Lilly

Evusheld (cilgavimab/tixagevimab) - AstraZeneca

Paxlovid (nirmatrelvir/ritonavir) - Pfizer

Lagevrio (molnupiravir) - Ridgeback Biotherap, Merck (MSD)

Xevudy (sotrovimab) - GSK, National Institutes of Health, Vir Biotech, National Institute of Allergy and Infectious Diseases

remdesivir - Generic mfg.

http://www.ncbi.nlm.nih.gov/pubmed/37896937

Alexander L Gintsburg; Andrei A Pochtovyi; Andrei E Siniavin; Andrei G Komarov; Anna A Iliukhina; Arina A Glavatskaya; Artem Y Shelkov; Daria D Kustova; Denis Y Logunov; Elena V Shidlovskaya; Inna V Dolzhikova; Lyudmila A Vasilchenko; Nadezhda A Kuznetsova; Olesia M Grinkevich; Olga G Shpakova; Vladimir A Gushchin

Oct 28, 2023